BidaskClub cut shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from a buy rating to a hold rating in a research note published on Friday morning.

MDRX has been the topic of a number of other research reports. Evercore ISI assumed coverage on shares of Allscripts Healthcare Solutions in a research report on Thursday. They set an outperform rating and a $17.50 target price on the stock. Robert W. Baird boosted their target price on shares of Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an outperform rating in a research report on Friday, November 3rd. SunTrust Banks downgraded shares of Allscripts Healthcare Solutions from a buy rating to a hold rating in a research report on Tuesday. They noted that the move was a valuation call. KeyCorp reiterated a hold rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 27th. Finally, Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a buy rating to a hold rating in a research report on Wednesday, November 8th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have issued a buy rating to the stock. Allscripts Healthcare Solutions presently has an average rating of Hold and an average target price of $15.66.

Allscripts Healthcare Solutions (NASDAQ MDRX) traded up $0.15 during trading on Friday, hitting $15.24. 1,401,766 shares of the company were exchanged, compared to its average volume of 2,270,000. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions has a 52 week low of $11.01 and a 52 week high of $16.12. The firm has a market cap of $2,780.00, a P/E ratio of -13.14, a PEG ratio of 2.13 and a beta of 1.32.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, November 2nd. The software maker reported $0.12 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.12. Allscripts Healthcare Solutions had a negative net margin of 12.23% and a positive return on equity of 6.53%. analysts anticipate that Allscripts Healthcare Solutions will post 0.46 earnings per share for the current fiscal year.

In other Allscripts Healthcare Solutions news, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $14.35, for a total transaction of $71,750.00. Following the transaction, the executive vice president now owns 191,607 shares in the company, valued at $2,749,560.45. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP James Hewitt sold 36,796 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the transaction, the senior vice president now owns 181,766 shares in the company, valued at approximately $2,564,718.26. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 56,796 shares of company stock worth $804,842. Corporate insiders own 0.75% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MDRX. Fisher Asset Management LLC acquired a new position in Allscripts Healthcare Solutions during the third quarter worth $33,351,000. Dimensional Fund Advisors LP raised its holdings in Allscripts Healthcare Solutions by 26.9% during the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock worth $117,026,000 after buying an additional 1,943,496 shares during the last quarter. Systematic Financial Management LP raised its holdings in Allscripts Healthcare Solutions by 1,215.3% during the third quarter. Systematic Financial Management LP now owns 1,853,300 shares of the software maker’s stock worth $26,372,000 after buying an additional 1,712,395 shares during the last quarter. State Street Corp raised its holdings in Allscripts Healthcare Solutions by 28.6% during the second quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after buying an additional 1,330,721 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Allscripts Healthcare Solutions by 70.8% in the second quarter. Northern Trust Corp now owns 2,930,365 shares of the software maker’s stock valued at $37,391,000 after purchasing an additional 1,215,020 shares during the last quarter.

WARNING: “Allscripts Healthcare Solutions (MDRX) Rating Lowered to Hold at BidaskClub” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/20/allscripts-healthcare-solutions-mdrx-rating-lowered-to-hold-at-bidaskclub.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.